Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Cytogenetics on malignant lymphoma].

¹Department of Internal Medicine, Kyoto University.

Rinsho Byori. the Japanese Journal of Clinical Pathology

|April 1, 1990

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dietary salt with nitric oxide deficiency induces nocturnal polyuria in mice via hyperactivation of intrarenal angiotensin II-SPAK-NCC pathway.

Communications biology·2022

Same author

Longitudinal association between polypharmacy and development of pruritus: a Nationwide Cohort Study in a Japanese Population.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Same author

Association of Education and Depressive Symptoms with Tooth Loss.

Journal of dental research·2020

Same author

Effects of Pathogen Density, Soil Moisture, and Soil pH on Biological Control of Clubroot in Chinese Cabbage by Heteroconium chaetospira.

Plant disease·2019

Same author

Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma.

Blood cancer journal·2017

Same author

Systematic characterization of human testis-specific actin capping protein β3 as a possible biomarker for male infertility.

Human reproduction (Oxford, England)·2017

Same journal

[The Role of Laboratory Medicine in Hematopoietic Stem Cell Transplantation "Echocardiogram"].

Rinsho byori. The Japanese journal of clinical pathology·2019

Same journal

[The Significance of Pulmonary Function Testing Before and After Allogeneic Stem Cell Transplantation].

Rinsho byori. The Japanese journal of clinical pathology·2019

Same journal

[Blood Transfusion Inspection].

Rinsho byori. The Japanese journal of clinical pathology·2019

Same journal

[The Role of Clinical Laboratory Technicians at Bone Marrow Transplantation : Blood Test].

Rinsho byori. The Japanese journal of clinical pathology·2019

Same journal

[The Foundation of Allogeneic Hematopoietic Stem Cell Transplantation and the Role of Clinical Laboratory Tests in This Field].

Rinsho byori. The Japanese journal of clinical pathology·2019

Same journal

[How to Interpret Data from Routine Laboratory Tests].

Rinsho byori. The Japanese journal of clinical pathology·2019

See all related articles

The 14q+ marker chromosome, common in lymphoid cancers, can be subclassified by specific translocations. This classification aids in understanding disease progression and developing targeted therapies for aggressive lymphoid cancers.

Area of Science:

Cytogenetics
Molecular Genetics
Oncology

Context:

The 14q+ marker chromosome is a frequent abnormality in lymphoid cancers.
Specific translocations involving chromosome 14 band q32 are key to understanding cancer development.

Purpose:

To propose a subclassification of 14q+ marker-positive lymphoid cancers based on precise translocations.
To link specific translocations to karyotype evolution and disease aggressiveness.

Summary:

Translocations involving chromosome 14 band q32 are common in lymphoid cancers, forming the 14q+ marker chromosome.
Recent molecular genetics advances support subclassifying these cancers by specific translocations.
Identifying juxtaposed genes or DNA sequences aids in subclassifying lymphoid cancers with chromosome changes.

Related Experiment Videos

Impact:

Enables a more refined understanding of lymphoid cancer heterogeneity.
Facilitates the identification of primary chromosome changes driving cancer progression.
Supports the development of targeted therapies for aggressive lymphoid cancers based on genetic subclasses.